Medication Recommendations for Standalone Inpatient Opioid Detox Without Methadone

Primary Medication: Buprenorphine

Buprenorphine is the most effective medication for managing opioid withdrawal in settings where methadone is unavailable, producing less severe withdrawal symptoms, fewer adverse effects, and higher treatment retention rates compared to non-opioid alternatives like clonidine or lofexidine 2
For inpatient detoxification, buprenorphine dosing should be based on withdrawal severity as measured by the Clinical Opiate Withdrawal Scale (COWS) 1
For moderate to severe withdrawal (COWS >8), administer 4-8 mg sublingual buprenorphine initially, then reassess after 30-60 minutes 3
Target a total daily dose of 16 mg for most patients, which can be administered once daily or divided into multiple doses 4

α2-Adrenergic Agonists, such as clonidine or lofexidine, can be used for autonomic symptoms (sweating, tachycardia, hypertension) 1, 3
Lofexidine is FDA-approved specifically for opioid withdrawal management 2
Benzodiazepines, such as lorazepam, can be used for anxiety, muscle cramps, and reducing catecholamine release, but monitor closely for respiratory depression 1, 2, 3
Antiemetics, such as promethazine, can be used for nausea and vomiting 1, 3
Antidiarrheals, such as loperamide, can be used for diarrhea 1, 3

Confirm time since last opioid use before initiating buprenorphine, with a recommended wait time of >12 hours for short-acting opioids and >24 hours for extended-release formulations 3, 4
Assess withdrawal severity using COWS 2, 3
For moderate to severe withdrawal (COWS >8), administer 4-8 mg sublingual buprenorphine initially, then reassess after 30-60 minutes 3
Target a total first-day dose of 8-16 mg based on withdrawal severity 5

Precipitated withdrawal can be avoided by ensuring patients are in sufficient withdrawal before administering buprenorphine 5
Inadequate symptom management can lead to patient discomfort and early discharge, highlighting the importance of addressing specific withdrawal symptoms 1
Lack of continuation planning can result in high relapse rates, emphasizing the need for discharge planning to include referrals to continued care 6
Regular assessment of vital signs and withdrawal symptoms is essential throughout the detoxification process 3